Telomeres and Brain Tumors

作者: Domenico La , Giovanni Raffa , Chiara Tomasello , MHammed Aguennouz , Antonino Germano

DOI: 10.5772/52426

关键词: Modern medicineAnaplastic astrocytomaTelomereCentral nervous systemInternal medicineMedicineOncologyHistologyMortality rateSurvival rateIncidence (epidemiology)

摘要: Brain tumors are a large and heterogeneous group of neoplasms affecting the central nervous system that, despite progress modern medicine, still represent great challenge for physicians all over world. The annual global age-standardized incidence primary malignant brain is ~3.7 per 100,000 males 2.6 females. Rates appear to be higher in more developed countries (males 5.8, females 4.1 100,000) than less 3.0 2.1 100,000). Conversely, both non-malignant about 10 14 cases 100,000/ year world, with white having highest rate. Males also generally have rates while nonmalignant tumors, primarily meningiomas. Worldwide mortality ~2.8 male 2.0 100,000. Mortality differ significantly by histology age. For example, glioblastoma multiforme (GBM) has 5-year survival rate 3.3%, low grade gliomas, such as pilocytic astrocytomas, oligo‐ dendrogliomas, ependymomas 70%, anaplastic astrocytoma, gliomas lymphomas 40% [1].

参考文章(176)
Kawase I, Matui K, Nitta T, Komiya T, Kikui M, Nakagawa K, Kobayashi M, Takada M, Masuda N, Takada Y, Yasumitu T, Ohno A, Fukuoka M, Hirashima T, Prognostic significance of telomeric repeat length alterations in pathological stage I-IIIA non-small cell lung cancer. Anticancer Research. ,vol. 20, pp. 2181- 2187 ,(2000)
Robert Rosenberg, Ralf Gertler, Dominik Stricker, Silke Lassmann, Martin Werner, Hjalmar Nekarda, Joerg Ruediger Siewert, Telomere Length and hTERT Expression in Patients with Colorectal Carcinoma Recent results in cancer research. ,vol. 162, pp. 177- 181 ,(2003) , 10.1007/978-3-642-59349-9_16
Titia de Lange, T-loops and the origin of telomeres Nature Reviews Molecular Cell Biology. ,vol. 5, pp. 323- 329 ,(2004) , 10.1038/NRM1359
E. Pennisi, CELL BIOLOGY:A Possible New Partner for Telomerase Science. ,vol. 282, pp. 1395- 1397 ,(1998) , 10.1126/SCIENCE.282.5393.1395
Catherine Daumas-Duport, Pascale Varlet, Marie-Louise Tucker, Frederic Beuvon, Pascale Cervera, Jean-Paul Chodkiewicz, Oligodendrogliomas. Part I : Patterns of growth, histological diagnosis, clinical and imaging correlations : A study of 153 cases Journal of Neuro-oncology. ,vol. 34, pp. 37- 59 ,(1997) , 10.1023/A:1005707203596
Cristina Garcia-Aranda, Carmen de Juan, Antonio Diaz-Lopez, Andres Sanchez-Pernaute, Antonio-Jose Torres, Eduardo Diaz-Rubio, Jose-Luis Balibrea, Manuel Benito, Pilar Iniesta, Correlations of telomere length, telomerase activity, and telomeric‐repeat binding factor 1 expression in colorectal carcinoma Cancer. ,vol. 106, pp. 541- 551 ,(2006) , 10.1002/CNCR.21625
Titia de Lange, Protection of mammalian telomeres Oncogene. ,vol. 21, pp. 532- 540 ,(2002) , 10.1038/SJ.ONC.1205080
Philipp J Hohensinner, Jörg J Goronzy, Cornelia M Weyand, None, Telomere dysfunction, autoimmunity and aging. Aging and Disease. ,vol. 2, pp. 524- 537 ,(2011)
C.M. Counter, A.A. Avilion, C.E. LeFeuvre, N.G. Stewart, C.W. Greider, C.B. Harley, S. Bacchetti, Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. The EMBO Journal. ,vol. 11, pp. 1921- 1929 ,(1992) , 10.1002/J.1460-2075.1992.TB05245.X
Lily I. Huschtscha, Anna Englezou, Jane R. Noble, Axel A. Neumann, Roger R. Reddel, Thomas R. Yeager, Telomerase-negative Immortalized Human Cells Contain a Novel Type of Promyelocytic Leukemia (PML) Body Cancer Research. ,vol. 59, pp. 4175- 4179 ,(1999)